Reviewed profile

food and beverage brand · public preview

Vascepa

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Headquarters
Ireland
Is this your company?Claim Vascepa to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Vascepa — no cold outreach.
Report a changeLog in for full recordLast reviewed 2 Jun 2026 · public preview data

Overview

What Vascepa covers.

Vascepa is an FDA-approved prescription medication containing icosapent ethyl, a purified form of eicosapentaenoic acid. It is indicated for use alongside statin therapy to reduce the risk of cardiovascular events in adults with established cardiovascular disease or diabetes and multiple risk factors, as well as to lower high triglyceride levels. The brand is developed and marketed by Amarin Pharma, Inc.

  • Positioned as a mainstream brand.
  • Headquartered in Ireland.

FAQ

Questions this page answers.

What does Vascepa do?

Vascepa is a food and beverage brand based in Ireland, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.